Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 18.02
+0.22 (1.24%)
May 29, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.72 billion as of May 29, 2026. Its market cap has increased by 14.49% in one year.
Market Cap
10.72B
Enterprise Value
7.97B
Revenue
1.20B
Ranking
n/a
PE Ratio
57.19
Stock Price
18.02
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.72B, a decrease of -61.87%. That is a compound annual growth rate of -20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 10.72B | -3.27% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 12.23B |
| Pacific Shuanglin Bio-pharmacy | 11.99B |
| Chengzhi | 11.95B |
| HitGen | 11.91B |
| Tibet Cheezheng Tibetan Medicine | 11.69B |
| Staidson (Beijing) BioPharmaceuticals | 11.27B |
| InventisBio | 10.93B |
| Chongqing Genrix Biopharmaceutical | 10.82B |